Jonathan Lyons, MD
Allergy & Immunology · San Diego, CANPI 1588860076
Payments from drug & device makers
What this record shows
This record is dominated by consulting fees: $11,422 of the $12,350 with a category attached, or 92.5%. 9 manufacturers reported payments, led by Sanofi US Services Inc. at 25.4% of the total.
Across 30 payments — averaging $411.66 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Sanofi US Services Inc.$3K
- Sanofi$3K
- Blueprint Medicines Corporation$2K
- Otsuka Pharmaceutical Co., Ltd.$2K
- Biogen$800
- Otsuka Pharmaceutical Development & Commercialization, Inc.$375
- plus $526 from 3 others
What the payments were for
- Consulting fees$11,42292%
- Food & beverage$9288%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Sanofi US Services Inc. | 1 | $3,140 |
| Sanofi | 4 | $2,579 |
| Blueprint Medicines Corporation | 5 | $2,480 |
| Otsuka Pharmaceutical Co., Ltd. | 2 | $2,450 |
| Biogen | 2 | $800 |
| Otsuka Pharmaceutical Development & Commercialization, Inc. | 1 | $375 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 12 | $240 |
| Grifols Shared Services North America, Inc. | 2 | $158 |
| AstraZeneca | 1 | $128 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$12,350 in reported general payments places this provider in the 80th percentile of 426 allergy & immunology providers in California.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Other allergy & immunology in San Diego
- Bob GengSan Diego$3.3M
- Andrew WhiteSan Diego$752K
- Marc RiedlSan Diego$725K
- Katharine WoessnerSan Diego$581K
- Bruce ZurawSan Diego$232K
- Brian StoneSan Diego$146K
- Bruce PrennerSan Diego$129K
- Seema AcevesSan Diego$122K
- Susan LaubachSan Diego$86K
- Harold HoffmanSan Diego$76K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.